Russia invests in cancer nanodrug capacity and safety
Rusnano, the group set up to promote Russia’s nanotechnology infrastructure, says nanodrug development partnership will improve patient access and cut cancer death rates across the country.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs